Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Synergistic inhibition of progesterone receptor-A/B signalling by simvastatin and mifepristone in human uterine leiomyomas.
Journal: Clinical and translational medicine
Published: February 10, 2024
The influence of COVID-19 infection-associated immune response on the female reproductive system†.
Journal: Biology of reproduction
Published: July 26, 2022
Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas.
Journal: Life sciences
Published: April 20, 2022
Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: February 15, 2022
Differential response to hypoxia in leiomyoma and myometrial cells.
Journal: Life sciences
Published: October 18, 2021
Simvastatin Inhibits Wnt/β-Catenin Pathway in Uterine Leiomyoma.
Journal: Endocrinology
Published: August 13, 2021
Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-β3 and Wnt/β-Catenin pathways.
Journal: Journal of cellular and molecular medicine
Published: June 28, 2021
Last Updated: 09/26/2026